A placebo controlled, single-blind, single oral dose study to determine the safety and immunogenicity of M01ZH09 typhoid vaccine (oral live S. typhi [Salmonella typhi] [Ty2 aroC ssaV] ZH9) in healthy paediatric subjects, aged five to 14 years inclusive, of Vietnamese origin

Trial Profile

A placebo controlled, single-blind, single oral dose study to determine the safety and immunogenicity of M01ZH09 typhoid vaccine (oral live S. typhi [Salmonella typhi] [Ty2 aroC ssaV] ZH9) in healthy paediatric subjects, aged five to 14 years inclusive, of Vietnamese origin

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Dec 2010

At a glance

  • Drugs Typhoid vaccine (Primary)
  • Indications Typhoid
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Emergent BioSolutions
  • Most Recent Events

    • 09 Jan 2008 Results have been reported in a company media release.
    • 09 Jan 2008 Final data analysis has been completed; the data from this analysis confirm that clinical endpoints have been met.
    • 17 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top